Sales of Flu drug Tamiflu did not fare so well last year
By Nho, Byung Chul | translator Alice Kang
25.01.08 05:58:46
가나다라
0
Oseltamivir sales fell to KRW 339 million at the peak of the COVID-19 pandemic in 2021 due to strict personal hygiene management
Roche Tamiflu-HanmiFlu raises KRW 2.6 billion and KRW 1.6 billion in the third quarter. respectively...sales expected to be cut to a third by 2023
Flu-infected children should avoid taking aspirin...may cause Reye's syndrome, including vomiting and cramps
The market for related preparations was valued at KRW 35.6 billion in 2023, the largest in 5 years.
By 3Q 2024, the oseltamivir market posted sales of KRW 6.2 billion; even when the sales of the fourth quarter are combined, it will be difficult to realize the KRW 10 billion mark.
However, given how flu alerts were issued from December last year to January this year, a spike in the drug’s sales is expected during the period.
The overall market for related ingredients has remained at the level of KRW 23.1 billion in 2019, and a
Nho, Byung Chul(sasiman@dailypharm.com)
If you want to see the full article, please JOIN US (click)